References
- Clemons M., Goss P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 2001; 344: 276–285, [PUBMED], [INFOTRIEVE], [CSA]
- Finck G., Barton D. L., Loprinzi C. L., Quella S. K., Sloan J. A. Definitions of hot flashes in breast cancer survivors. J. Pain Symptom Manage. 1998; 16: 327–333, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Goldberg R. M., Loprinzi C. L., O'Fallon J. R., Veeder M. H., Miser A. W., Mailliard J. A., Michalak J. C., Dose A. M., Rowland K. M., Jr., Burnham N. L. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J. Clin. Oncol. 1994; 12: 155–158, [PUBMED], [INFOTRIEVE]
- Bergmans M. G., Merkus J. M., Corbey R. S., Schellekens L. A., Ubachs J. M. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987; 9: 227–234, [PUBMED], [INFOTRIEVE]
- Nesheim B. I., Saetre T. Reduction of menopausal hot flushes by methyldopa. A double blind crossover trial. Eur. J. Clin. Pharmacol. 1981; 20: 413–416, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loprinzi C. L., Michalak J. C., Quella S. K., O'Fallon J. R., Hatfield A. K., Nelimark R. A., Dose A. M., Fischer T., Johnson C., Klatt N. E., Bate W. W., Rospond R. M., Oesterling J. E. Megestrol acetate for the prevention of hot flashes. N. Engl. J. Med. 1994; 331: 347–352, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Loprinzi C. L., Pisansky T. M., Fonseca R., Sloan J. A., Zahasky K. M., Quella S. K., Novotny P. J., Rummans T. A., Dumesic D. A., Perez E. A. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J. Clin. Oncol. 1998; 16: 2377–2381, [PUBMED], [INFOTRIEVE]
- Loprinzi C. L., Kugler J. W., Sloan J. A., Mailliard J. A., LaVasseur B. I., Barton D. L., Novotny P. J., Dakhil S. R., Rodger K., Rummans T. A., Christensen B. J. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059–2063, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loprinzi C. L., Sloan J. A., Perez E. A., Quella S. K., Stella P. J., Mailliard J. A., Halyard M. Y., Pruthi S., Novotny P. J., Rummans T. A. Phase III evaluation of fluoxetine for treatment of hot flashes. J. Clin. Oncol. 2002; 20: 1578–1583, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stearns V., Isaacs C., Rowland J., Crawford J., Ellis M. J., Kramer R., Lawrence W., Hanfelt J. J., Hayes D. F. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann. Oncol. 2000; 11: 17–22, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–1575, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kessler R. C., Davis R. B., Foster D. F., Van Rompay M. I., Walters E. E., Wilkey S. A., Kaptchuk T. J., Eisenberg D. M. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann. Intern. Med. 2001; 135: 262–268, [PUBMED], [INFOTRIEVE], [CSA]
- Morris K. T., Johnson N., Homer L., Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am. J. Surg. 2000; 179: 407–411, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Oddens B. J. The climacteric cross-culturally: the International Health Foundation South-east Asia study. Maturitas 1994; 19: 155–156, [PUBMED], [INFOTRIEVE], [CSA]
- Barton D. L., Loprinzi C. L., Quella S. K., Sloan J. A., Veeder M. H., Egner J. R., Fidler P., Stella P. J., Swan D. K., Vaught N. L., Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J. Clin. Oncol. 1998; 16: 495–500, [PUBMED], [INFOTRIEVE]
- Wade C., Kronenberg F., Kelly A., Murphy P. A. Hormone-modulating herbs: implications for women's health. J. Am. Med. Women's Assoc. 1999; 54: 181–183
- Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv. Ther. 1998; 15: 45–53, [PUBMED], [INFOTRIEVE], [CSA]
- Pepping J. Black cohosh: Cimicifugo racemoso. Am. J. Health-Syst. Pharm. 1999; 56: 1400–1402, [CSA]
- Lieberman S. A review of the effectiveness of Cimicifugo racemoso (black cohosh) for the symptoms of menopause. J. Women's Health 1998; 7: 525–529
- Jacobson J. S., Troxel A. B., Evans J., Klaus L., Vahdat L., Kinne D., Lo K. M., Moore A., Rosenman P. J., Kaufman E. L., Neugut A. I., Grann V. R. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J. Clin. Oncol. 2001; 19: 2739–2745, [PUBMED], [INFOTRIEVE]
- Zava D. T., Dollbaum C. M., Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 1998; 217: 369–378, [PUBMED], [INFOTRIEVE], [CSA]
- Blumenthal M. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medications. American Botanical Council, Austin 1998; 90
- Sloan J. A., Loprinzi C. L., Novotny P. J., Barton D. L., Lavasseur B. I., Windschitl H. Methodologic lessons learned from hot flash studies. J. Clin. Oncol. 2001; 19: 4280–4290, [PUBMED], [INFOTRIEVE]
- DiPaola R. S., Zhang H., Lambert G. H., Meeker R., Licitra E., Rafi M. M., Zhu B. T., Spaulding H., Goodin S., Toledano M. B., Hait W. N., Gallo M. A. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N. Engl. J. Med. 1998; 339: 785–791, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Quella S. K., Loprinzi C. L., Barton D. L., Knost J. A., Sloan J. A., LaVasseur B. I., Swan D., Krupp K. R., Miller K. D., Novotny P. J. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J. Clin. Oncol. 2000; 18: 1068–1074, [PUBMED], [INFOTRIEVE]
- Stolze H. An alternative to treat menopausal complaints [German]. Gyne 1982; 1: 14–16
- Jarry H., Harnischfeger G., Duker E. The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors [German]. Planta Med. 1985; 4: 316–319, [PUBMED], [INFOTRIEVE]
- Liu J., Burdette J. E., Xu H., Gu C., van Breeman R. B., Bhat K. P., Booth N., Constantinou A. I., Pezzuto J. M., Fong H. H., Farnsworth N. R., Bolton J. L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. 2001; 49: 2472–2479, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Duker E. M., Kopanski L., Jarry H., Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med. 1991; 57: 420–424, [PUBMED], [INFOTRIEVE]
- Liao J. F., Jan Y. M., Huang S. Y., Wang H. H., Yu L. L., Chen C. F. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc. Natl. Sci. Counc. Repub. China, B 1995; 19: 151–158
- Loprinzi C. L., Barton D. L., Sloan J. A., Smith D. R., Pruthi S., Novotny P. J., Perez E. A., Christensen B. A. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clinic Proceedings 2002; 77: 1159–1163, [PUBMED], [INFOTRIEVE], [CSA]